PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma
about
RSK isoforms in cancer cell invasion and metastasisStructure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPKNovel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressivenessPhosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoterRSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics.Targetting PED/PEA-15 for diabetes treatment.Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients.
P2860
Q28308636-AA7DD3E3-99F4-487E-86F6-19707CC39FCFQ54749697-7F5738CD-6631-4BBB-A1F9-89FB601B791DQ54813265-FB4E2F7C-DBA2-4359-B6DC-911C9798F628Q54835813-6492D58C-3C5C-4C69-9C1F-B6997EC86FECQ54897618-ED523327-2F8E-4546-80AA-342764EF77C9Q54901875-6BAAC756-4700-4A67-8D65-F202E80B29D7Q54901878-9CEB1BB4-6467-4ED6-A1BA-3644275E2147Q54907330-10E783C9-394C-45CC-9307-0C2626A9DCCFQ54930471-76D421F0-9888-425F-ADCD-76A6DFA6A89DQ54930830-C86EEA5C-C4DE-426D-AED2-AF889FC8F76FQ54953553-A047FB58-2E5E-4D04-960A-89CB71271F89Q54953554-8FF71831-17DE-4C1F-940E-7207558F1FFBQ54953556-5E2F4D3E-98A6-4803-8CEC-3175039588DDQ54953578-31249C1D-235A-4C5C-8240-ECAE643F3AAEQ54953580-D324FF36-2ADB-4611-A453-8106DE280B0BQ54954411-3EE4D0F4-C4A1-4B92-88A8-081F4EDB91E4Q54954442-1076CCA2-1AF4-460C-8631-A1738D59EBB3Q54954472-CCD39ECB-F7D2-4ABB-B709-A185A1F55FF4Q54954992-AEF529B1-21E3-482C-9547-900BB708AEB9Q54972194-59CD39C8-EBBE-48F7-B923-BBEE0F155199Q54972195-E2D3D43D-84A4-4F71-99D5-AC5C0ACA4C7EQ54972929-18C36933-CE9F-41CF-B3D9-1FF4F540215DQ54990144-733EC3AE-8A07-4554-BBE8-90FE60A0EE9AQ7390126-76BA3243-89F5-41E7-B174-53903D3AFF76
P1343
Q26827485-2CD38956-4D39-4506-B05D-74A109B5C7F3Q27677302-ED10DE26-5BCD-4F98-B5C0-A18DF5A88C0CQ33578405-CC9F3995-D140-4A63-AC97-AC961F0839FFQ34024181-C7DD7AA5-5D2C-4CFA-B68D-719B03B949BAQ35966204-FF8C7392-8567-49A1-AB38-75D8CF4D1068Q36235303-6EE5B3D6-3C21-49D8-B402-335EE3F9F0B3Q37694863-81E96878-B9DC-42EA-BE82-EE672F577CC6Q39232367-F60F4E44-1677-4ED2-95C7-5DE092941EEDQ43905855-91115857-0879-47DA-8AF6-AD9531D3CDC5Q53011367-25FE7E5F-1CA7-4C6E-93D7-53CF80F8BD84
P2860
PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@ast
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@en
type
label
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@ast
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@en
prefLabel
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@ast
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@en
P2093
P2860
P4510
P50
P356
P1476
PEA15 impairs cell migration a ...... ood prognosis in neuroblastoma
@en
P2093
André S Bachmann
Florian J Sulzmaier
Joanna E Gawecka
John Opoku-Ansah
Maisel J Caliva
Randal K Wada
P2860
P304
P356
10.1002/IJC.27415
P577
2012-01-31T00:00:00Z